BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 2501330)

  • 41. [Empirical cefepime monotherapy in febrile neutropenia].
    Kliasova GA
    Antibiot Khimioter; 2003; 48(7):33-7. PubMed ID: 14628577
    [No Abstract]   [Full Text] [Related]  

  • 42. The management of febrile episodes in-neutropenic cancer.
    Bishop JF; McLennan R; Whiteside MG
    Med J Aust; 1977 Apr; 1(14):473-5. PubMed ID: 865367
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Management of the febrile neutropenic patient.
    Mandell LA
    Can Med Assoc J; 1983 Apr; 128(8):915-7. PubMed ID: 6831337
    [No Abstract]   [Full Text] [Related]  

  • 44. [Infections in neutropenic patients].
    Berenguer J
    Enferm Infecc Microbiol Clin; 1995 Feb; 13(2):113-20. PubMed ID: 7711117
    [No Abstract]   [Full Text] [Related]  

  • 45. A comparison of aztreonam plus vancomycin and imipenem plus vancomycin as initial therapy for febrile neutropenic cancer patients.
    Raad II; Whimbey EE; Rolston KV; Abi-Said D; Hachem RY; Pandya RG; Ghaddar HM; Karl CL; Bodey GP
    Cancer; 1996 Apr; 77(7):1386-94. PubMed ID: 8608520
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ceftazidime with or without vancomycin vs. cephalothin, carbenicillin and gentamicin as the initial therapy of the febrile neutropenic pediatric cancer patient.
    Granowetter L; Wells H; Lange BJ
    Pediatr Infect Dis J; 1988 Mar; 7(3):165-70. PubMed ID: 3282214
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Teicoplanin in combination therapy for febrile episodes in neutropenic and non-neutropenic paediatric patients.
    Lemerle S; de La Rocque F; Lamy R; Fremaux A; Bernaudin F; Lobut JB; Reinert P
    J Antimicrob Chemother; 1988 Jan; 21 Suppl A():113-6. PubMed ID: 2965122
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Fever in the neutropenic patient].
    Milpied N
    Rev Prat; 2001 Mar; 51(6):633-7. PubMed ID: 11345865
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Fever in neutropenic patients: analysis of 109 episodes and 15 superinfections (author's transl)].
    Baro J; Richard C; Esteban J; Iriondo A; Conde E; Garijo J; Zubizarreta A
    Sangre (Barc); 1981; 26(4):417-26. PubMed ID: 7292225
    [No Abstract]   [Full Text] [Related]  

  • 50. Vancomycin plus gentamicin and cotrimoxazole for prevention of infections in neutropenic cancer patients (a comparative, placebo-controlled pilot study).
    Malarme M; Meunier-Carpentier F; Klastersky J
    Eur J Cancer Clin Oncol; 1981 Dec; 17(12):1315-22. PubMed ID: 7040086
    [No Abstract]   [Full Text] [Related]  

  • 51. Management of bacterial infections in severely neutropenic subjects.
    Vincent PC; Fabre S; Jennis F
    Med J Aust; 1977 Oct; 2(3 Pt 2 Suppl):30-3. PubMed ID: 244772
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sepsis in febrile neutropenic children with cancer.
    Langley J; Gold R
    Pediatr Infect Dis J; 1988 Jan; 7(1):34-7. PubMed ID: 3340456
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Empiric treatment of infections in neutropenic patients with cancer.
    Klastersky J
    Rev Infect Dis; 1983; 5 Suppl 1():S21-31. PubMed ID: 6342096
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Systemic broad-spectrum antimicrobial prophylaxis in hematological patients after intensive antineoplastic chemotherapy.
    Verlicchi F; Ricci P; Bassi A; Benfenati D; Bandini G; Rosti G; Calori E; Borghi C; Tura S
    Haematologica; 1990; 75(1):91-3. PubMed ID: 2338294
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Empirical antibiotics for febrile neutropenic cancer patients.
    Hathorn JW
    Eur J Cancer Clin Oncol; 1989; 25 Suppl 2():S43-51. PubMed ID: 2693109
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cefepime monotherapy as an empirical initial treatment of patients with febrile neutropenia.
    Montalar J; Segura A; Bosch C; Galan A; Juan O; Molins C; Giner V; Aparicio J
    Med Oncol; 2002; 19(3):161-6. PubMed ID: 12482126
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Empiric antibiotic therapy for granulocytopenic cancer patients.
    Schimpff SC
    Am J Med; 1986 May; 80(5C):13-20. PubMed ID: 3521270
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ceftriaxone and amikacin as single daily dose in the empiric therapy for febrile episodes in neutropenic patients.
    Martino P; Girmenia C; Raccah R; Micozzi A; Cimino G; Mandelli F
    Haematologica; 1990; 75(1):69-74. PubMed ID: 2338290
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunoprophylaxis of gram-negative infections: background for a prophylactic study of purified anticore-glycolipid immunoglobulins in neutropenic patients.
    Glauser MP
    Schweiz Med Wochenschr Suppl; 1983; 14():35-9. PubMed ID: 6361989
    [No Abstract]   [Full Text] [Related]  

  • 60. Empiric single agent or combination antibiotic therapy for febrile episodes in neutropenic patients: an overview.
    Lieschke GJ; Bell D; Rawlinson W; Green MD; Sheridan W; Morstyn G; Stuart-Harris R; Kefford RF; Levi J; Sorrell T
    Eur J Cancer Clin Oncol; 1989; 25 Suppl 2():S37-42. PubMed ID: 2693108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.